Mirjam Langeveld Selected Research

Type 2 Diabetes Mellitus (MODY)

1/2012	Treatment of genetically obese mice with the iminosugar N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin reduces body weight by decreasing food intake and increasing fat oxidation.
11/2009	Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mirjam Langeveld Research Topics

Disease

6	Insulin Resistance 01/2012 - 03/2008
5	Fabry Disease (Fabry's Disease) 08/2020 - 01/2017
3	Obesity 01/2012 - 03/2007
3	Gaucher Disease (Gaucher's Disease) 03/2008 - 03/2007
2	Mucolipidoses (Sialidosis) 01/2021 - 01/2018
2	Cardiomyopathies (Cardiomyopathy) 01/2020 - 01/2019
2	Muscular Diseases (Myopathy) 01/2020 - 01/2019
2	Rhabdomyolysis 01/2020 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2012 - 11/2009
2	Body Weight (Weight, Body) 01/2012 - 11/2009
1	Dysostoses 01/2021
1	Mucopolysaccharidoses 01/2021
1	Birth Weight (Birth Weights) 11/2020
1	Atrial Fibrillation 01/2020
1	VLCAD deficiency 01/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Brain Infarction 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Craniosynostoses (Craniosynostosis) 11/2018
1	Hypoparathyroidism 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Neurologic Manifestations (Neurological Manifestations) 01/2017
1	Glycogen Storage Disease (Glycogenosis) 12/2015
1	Adenoma (Adenomas) 12/2015
1	Weight Loss (Weight Reduction) 01/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011
1	Hepatomegaly 03/2008
1	Hyperglycemia 03/2007

Drug/Important Bio-Agent (IBA)

4	Insulin (Novolin)FDA Link 01/2012 - 03/2008
4	GlycosphingolipidsIBA 01/2011 - 03/2008
3	LipidsIBA 01/2020 - 03/2007
3	EnzymesIBA 01/2019 - 11/2009
2	Carnitine (L-Carnitine)FDA LinkGeneric 11/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 08/2020 - 01/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2020
2	migalastatIBA 01/2020 - 11/2019
2	N- (5- adamantane- 1- yl- methoxy- pentyl)deoxynojirimycinIBA 01/2012 - 11/2009
2	Glucosylceramides (Glucocerebrosides)IBA 03/2008 - 03/2008
1	GlycosaminoglycansIBA 01/2021
1	mutalipocin IIIBA 01/2021
1	agalsidase alfaIBA 08/2020
1	AntibodiesIBA 08/2020
1	Carnitine palmitoyl transferase 2 deficiencyIBA 01/2020
1	Long-Chain-3-Hydroxyacyl-CoA DehydrogenaseIBA 01/2020
1	Protons (Proton)IBA 01/2020
1	CarbohydratesIBA 01/2020
1	GalactosidasesIBA 01/2020
1	CholesterolIBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	Uridine Diphosphate (UDP)IBA 01/2018
1	Dicarboxylic AcidsIBA 01/2018
1	acylcarnitineIBA 01/2018
1	Mitochondrial Trifunctional ProteinIBA 01/2018
1	Familial apoceruloplasmin deficiencyIBA 01/2017
1	globotriaosyl lysosphingolipidIBA 01/2017
1	GlycogenIBA 12/2015
1	ceramide glucosyltransferaseIBA 11/2009
1	SphingolipidsIBA 05/2009
1	G(M3) GangliosideIBA 03/2008
1	chitotriosidaseIBA 03/2008
1	CeramidesIBA 03/2008
1	Insulin ReceptorIBA 03/2008
1	AdiponectinIBA 03/2007
1	Glucose (Dextrose)FDA LinkGeneric 03/2007

Therapy/Procedure

3	Enzyme Replacement Therapy 01/2020 - 01/2017
2	Therapeutics 01/2020 - 11/2019
1	Ventriculoperitoneal Shunt 11/2018
1	Sutures (Suture) 11/2018
1	Liver Transplantation 12/2015
1	Caloric Restriction 01/2013